Effects of levosimendan in patients with acute heart failure and cardiorenal syndrome

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. INTRODUCTION: Cardiorenal syndrome (CRS) is common in patients with acute heart failure (AHF) and is associated with poor prognosis. Levosimendan (LVS) is an inodilator used in AHF and has beneficial effects on renal function (RF). However, it...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur Heart J Acute Cardiovasc Care
Päätekijät: Ribeiro Da Silva, M, Santos Silva, G, Caeiro, D, Passos Silva, M, Guerreiro, C, Teixeira, P, Ribeiro Queiros, P, Brandao, M, Ferreira, D, Sousa, O, Dias, A, Rodrigues, A, Braga, P
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2021
Aiheet:
16.4.1 - Pharmacotherapy
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264012/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ehjacc/zuab020.028
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia